• Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial 

      Bermejo, Javier; Yotti, Raquel; García-Orta, Rocío; Sánchez-Fernández, Pedro L.; Castaño, Mario; Segovia-Cubero, Javier; Escribano-Subías, Pilar; San Román, José Alberto; Borrás, Xavier; Alonso-Gómez, Ángel; Botas, Javier; Crespo-Leiro, María Generosa; Velasco, Sonia; Bayés-Genís, Antoni; López, Amador; Muñoz-Aguilera, Roberto; Teresa, Eduardo de; González-Juataney, José R.; Evangelista, Arturo; Mombiela, Teresa; González-Mansilla, Ana; Elízaga, Jaime; Martín-Moreiras, Javier; González-Santos, José M.; Moreno-Escobar, Eduardo; Fernández-Avilés, Francisco (Oxford University Press, 2018-04-14)
      [Abstract] Aims: We aimed to determine whether treatment with sildenafil improves outcomes of patients with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD). Methods and results: ...